TY - JOUR
T1 - Intraosseous vs. Intravenous Access during Out-of-hospital Cardiac Arrest
T2 - A Bayesian Secondary Analysis of a Randomised Clinical Trial
AU - Vallentin, Mikael Fink
AU - Holmberg, Mathias J
AU - Granfeldt, Asger
AU - Klitgaard, Thomas Lass
AU - Mikkelsen, Søren
AU - Folke, Fredrik
AU - Christensen, Helle Collatz
AU - Povlsen, Amalie Ling
AU - Petersen, Alberthe Hjort
AU - Winther, Sofie
AU - Frilund, Lea Wildt
AU - Meilandt, Carsten
AU - Winther, Kristian Blumensaadt
AU - Bach, Allan
AU - Dissing, Thomas H
AU - Terkelsen, Christian Juhl
AU - Christensen, Steffen
AU - Rasmussen, Line Kirkegaard
AU - Mortensen, Lone Riis
AU - Loldrup, Mads Ladefoged
AU - Elkmann, Thomas
AU - Nielsen, Anders Gunnar
AU - Runge, Charlotte
AU - Klæstrup, Elise
AU - Holm, Jimmy Højberg
AU - Bak, Mikkel
AU - Nielsen, Lars-Gustav Rahbek
AU - Pedersen, Mette
AU - Kjærgaard-Andersen, Gunhild
AU - Hansen, Peter Martin
AU - Brøchner, Anne Craveiro
AU - Christensen, Erika Frischknecht
AU - Nielsen, Frederik Mølgaard
AU - Nissen, Christian Gade
AU - Bjørn, Jeppe Waldstrøm
AU - Burholt, Peter
AU - Obling, Laust E R
AU - Duus Holle, Sarah Louise
AU - Russell, Lene
AU - Alstrøm, Henrik
AU - Hestad, Søren
AU - Fogtmann, Tanja Hesse
AU - Hove Buciek, Jens Ulrik
AU - Jakobsen, Karina
AU - Krag, Mette
AU - Sandgaard, Michael
AU - Sindberg, Birthe
AU - Andersen, Lars W
N1 - Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.
PY - 2025/7
Y1 - 2025/7
N2 - AIM OF THE STUDY: This study aimed to apply a Bayesian probabilistic framework to the Intravenous vs. Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial data to evaluate the likelihood of benefit for each vascular access method while incorporating various prior beliefs.METHODS: The IVIO trial was a randomised trial comparing intraosseous to intravenous access in 1,479 adults with non-traumatic out-of-hospital cardiac arrest. Bayesian analyses were pre-planned in the protocol and conducted using both non-informative and informative priors to calculate posterior probabilities for sustained return of spontaneous circulation, 30-day survival, and 30-day survival with a favourable neurologic outcome.RESULTS: Using non-informative priors for return of spontaneous circulation, the posterior probabilities that the effect of either vascular access exceeds the hypothesised difference were 1.2% (risk ratio >1.27, favouring intraosseous access) and < 0.1% (risk ratio < 0.79 [1/1.27], favouring intravenous access). For 30-day survival and survival with a favourable neurologic outcome, the posterior probability that the risk ratio for intraosseous compared to intravenous access is between 0.83 (1/1.2) and 1.2 was 58% and 55%, respectively. For all analyses with informative priors, the results did not provide probabilities strongly favouring either intraosseous or intravenous access.CONCLUSIONS: The probability of a clinically meaningful difference in return of spontaneous circulation between intraosseous and intravenous access for out-of-hospital cardiac arrest was very low, while results for 30-day outcomes were uncertain, with no strong evidence favouring either method. Trial registration EU Clinical Trials number: 2022-500744-38-00 ClinicalTrials.gov number: NCT05205031.
AB - AIM OF THE STUDY: This study aimed to apply a Bayesian probabilistic framework to the Intravenous vs. Intraosseous Vascular Access for Out-of-Hospital Cardiac Arrest (IVIO) trial data to evaluate the likelihood of benefit for each vascular access method while incorporating various prior beliefs.METHODS: The IVIO trial was a randomised trial comparing intraosseous to intravenous access in 1,479 adults with non-traumatic out-of-hospital cardiac arrest. Bayesian analyses were pre-planned in the protocol and conducted using both non-informative and informative priors to calculate posterior probabilities for sustained return of spontaneous circulation, 30-day survival, and 30-day survival with a favourable neurologic outcome.RESULTS: Using non-informative priors for return of spontaneous circulation, the posterior probabilities that the effect of either vascular access exceeds the hypothesised difference were 1.2% (risk ratio >1.27, favouring intraosseous access) and < 0.1% (risk ratio < 0.79 [1/1.27], favouring intravenous access). For 30-day survival and survival with a favourable neurologic outcome, the posterior probability that the risk ratio for intraosseous compared to intravenous access is between 0.83 (1/1.2) and 1.2 was 58% and 55%, respectively. For all analyses with informative priors, the results did not provide probabilities strongly favouring either intraosseous or intravenous access.CONCLUSIONS: The probability of a clinically meaningful difference in return of spontaneous circulation between intraosseous and intravenous access for out-of-hospital cardiac arrest was very low, while results for 30-day outcomes were uncertain, with no strong evidence favouring either method. Trial registration EU Clinical Trials number: 2022-500744-38-00 ClinicalTrials.gov number: NCT05205031.
UR - http://www.scopus.com/inward/record.url?scp=105005228141&partnerID=8YFLogxK
U2 - 10.1016/j.resuscitation.2025.110634
DO - 10.1016/j.resuscitation.2025.110634
M3 - Journal article
C2 - 40348355
SN - 0300-9572
VL - 212
SP - 110634
JO - Resuscitation
JF - Resuscitation
M1 - 110634
ER -